A Shot at Double Protection: Join Our COVID & Flu Vaccine Trial!
In the ongoing battle against infectious diseases, one thing is for certain: a strong immune system is your best defense. […]
Rochester Clinical Research Partners with Rochester Hope to Uplift the Community
RCR announces partnership with a local non-profit called Rochester Hope [Rochester, New York] — Rochester Clinical Research (RCR) has announced
Antibody to Safeguard Infants from RSV Receives FDA Approval
Respiratory Syncytial Virus, commonly referred to as RSV, has been making headlines more frequently than ever before. This highly contagious
A Phase 3 Smoking Cessation Study That RCR Worked On Shows Cytisinicline Is Well Tolerated and Effective In Helping People Quit
Rochester Clinical Research takes pride in its involvement in a phase 3 smoking cessation study, which has yielded promising and
Rochester Clinical Research (RCR) Supports the Rochester Puerto Rican Festival, Offers Ticket Giveaway
FOR IMMEDIATE RELEASE Rochester Clinical Research (RCR) Supports the Rochester Puerto Rican Festival, Offers Ticket Giveaway Enter for a chance
Mrs. Kasha Davis to Speak at Rochester Clinical Research Allyship Lunch & Learn
Popular local drag performer will speak about diversity and inclusion at a special Pride event on Thursday June 29th. Rochester
Rochester Clinical Research Wins “Best Clinical Trial Site Company” At The 2023 World Vaccine Congress Awards!
Rochester Clinical Research is thrilled to announce that we have been awarded the Vaccine Industry Excellence (VIE) award for “Best
RCR Helps Acute Migraine Nasal Spray Get FDA Approved
Rochester Clinical Research takes great pride in its contribution to Pfizer’s groundbreaking study on Zavzpret (zavegepant) migraine nasal spray, which
RCR’s, Dr. Matthew Davis, on Channel 10 News talking about our pediatric Lyme Disease study
Doctors working to develop a vaccine for Lyme Disease Patrick Moussignac News10NBCApril 26, 2023 – 5:56 PM ROCHESTER, N.Y. –